Skip to main content
. 2022 Nov 9;29(1):e3457. doi: 10.1002/psc.3457

FIGURE 1.

FIGURE 1

(A) Structure‐based design of a peptide‐based targeted covalent inhibitor. Top: Ligand binding site (grey) in proximity to a nucleophile on the protein surface. Bottom: Introduction of a covalent modifier (orange) in the peptide ligand (blue) results in the desired covalent inhibitor. (B) Chemical structures of selected modifiers discussed in this review.